Clinical trials and their current trials…. jlolds clinical trials, pharmacogenomics July 14, 2013 1 Minute Bottom line, their high cost and inability to handle individual differences in pharmaco-genomics, NYT editorial here. Share this:TwitterFacebookLike this:Like Loading... Published by jlolds Native Angeleno, professor of Neuroscience and Public Policy at George Mason University View all posts by jlolds Published July 14, 2013